Format
Sort by

Send to

Choose Destination

Search results

Items: 8

1.

Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development.

Cook AD, Pobjoy J, Steidl S, Dürr M, Braine EL, Turner AL, Lacey DC, Hamilton JA.

Arthritis Res Ther. 2012 Sep 20;14(5):R199. doi: 10.1186/ar4037.

2.

Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis.

Cook AD, Turner AL, Braine EL, Pobjoy J, Lenzo JC, Hamilton JA.

Arthritis Rheum. 2011 Aug;63(8):2340-51. doi: 10.1002/art.30354.

3.

Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.

Cook AD, De Nardo CM, Braine EL, Turner AL, Vlahos R, Way KJ, Beckman SK, Lenzo JC, Hamilton JA.

Arthritis Res Ther. 2010;12(2):R37. doi: 10.1186/ar2946. Epub 2010 Mar 2.

4.

The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.

Cook AD, Vlahos R, Massa CM, Braine EL, Lenzo JC, Turner AL, Way KJ, Hamilton JA.

Thromb Haemost. 2006 Apr;95(4):659-67.

PMID:
16601837
5.
6.
7.

Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.

Cook AD, Braine EL, Campbell IK, Hamilton JA.

Am J Pathol. 2002 Mar;160(3):917-26.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk